Simon Tremblay

Simon Tremblay, PharmD, PhD, serves as the Director and Clinical Development Lead for CDL VEL-101 at Veloxis Pharmaceuticals, Inc., overseeing end-to-end clinical program management since April 2022. Prior experience includes roles as Director and Associate Director of Regulatory & Scientific Affairs at CTI Clinical Trial and Consulting Services, and various positions at the University of Cincinnati, including Director of the Antihumoral Therapies Program. Simon has a strong educational background with a PhD in Epidemiology and a PharmD, along with multiple advanced degrees in pharmaceutical sciences and pharmacy practice from prestigious institutions.